Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.

Arthritis and rheumatism - 1 Apr 2008

Delgado Mario, Robledo Gema, Rueda Blanca, Varela Nieves, O'Valle Francisco, Hernandez-Cortes Pedro, Caro Marta, Orozco Gisela, Gonzalez-Rey Elena, Martin Javier

Abstract excerpt

OBJECTIVE: Vasoactive intestinal peptide (VIP) has been shown to be one of the endogenous factors involved in the maintenance of immune tolerance. Administration of VIP ameliorates clinical signs in various experimental autoimmune disorders. This study was undertaken to investigate whether the exacerbated inflammatory autoimmune response in rheumatoid arthritis (RA) might result directly from altered expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Experimental
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Haplotypes

Share to Polymorphism, Single Nucleotide

Share to Vasoactive Intestinal Peptide

Source

Identifiers

PMID: 18383379
DOI: 10.1002/art.23482

Genes

VIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.PMID 18383379Read ↗

Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.Semantic proximity Read ↗

In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen‐induced arthritisSemantic proximity Read ↗

Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effectSemantic proximity Read ↗

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis.Semantic proximity Read ↗

Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.Semantic proximity Read ↗

Targeting VIP and PACAP Receptor Signalling: New Therapeutic Strategies in Multiple SclerosisSemantic proximity Read ↗

VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis.Semantic proximity Read ↗

Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1.Semantic proximity Read ↗

Finding functional gaps: integrative analysis of VPAC1- and VPAC2-mediated signalling pathways in human lymphocytesSemantic proximity Read ↗

Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy.Semantic proximity Read ↗

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.Semantic proximity Read ↗

Vasoactive Intestinal Peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.